Announcements Trials
Browse Landscape

Phase

Phase 2 8Phase 3 3Phase NA 1Phase 2/3 1Phase 1/2 1Phase 1 1

Status

Terminated 1Recruiting 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Breast Neoplasms 13Rectal Neoplasms 10Esophageal Neoplasms 7Colorectal Neoplasms 7Stomach Neoplasms 6Esophageal Squamous Cell Carcinoma 6Uterine Cervical Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Adenocarcinoma Of Esophagus 5Squamous Cell Carcinoma of Head and Neck 4Neuroblastoma 4Neoplasm Metastasis 4Nasopharyngeal Carcinoma 4Colonic Neoplasms 4Sarcoma 3Pancreatic Neoplasms 3Lung Neoplasms 3Liposarcoma 3Inflammatory Breast Neoplasms 3Head and Neck Neoplasms 3Fallopian Tube Neoplasms 3Carcinoma, Ovarian Epithelial 3Prostatic Neoplasms 2Peritoneal Neoplasms 2Ovarian Neoplasms 2Neuroectodermal Tumors, Primitive, Peripheral 2Multiple Myeloma 2Melanoma 2Hemangiosarcoma 2Hemangiopericytoma, Malignant 2

Interventions

Gemcitabine 74Fluorouracil 31Oxaliplatin 21Leucovorin 21130-nm albumin-bound paclitaxel 17Capecitabine 14Irinotecan 12Albumin-Bound Paclitaxel 10irinotecan sucrosofate 8Radiotherapy 6Taxes 5Erlotinib Hydrochloride 5folfirinox 4rubitecan 3Surgical Procedures, Operative 3Specimen Handling 3Pancreaticojejunostomy 3Neoadjuvant Therapy 3Drug Therapy 3Cisplatin 3Chemotherapy, Adjuvant 3ruxolitinib 2masitinib 2dehydroftorafur 2Saline Solution 2S 1 (combination) 2Paclitaxel 2GV1001 peptide 2Fentanyl 2Bevacizumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Pancreatic Neoplasms × Neoadjuvant Therapy × Clear all
NCT07081360 2025-08-29

Neoadjuvant vs Upfront Surgery for Resectable Pancreatic Cancer and Periampullary Cancer

Minia University

Phase 3 Recruiting
262 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT01314027 2019-07-25

Adjuvant Versus Neoadjuvant Plus Adjuvant Chemotherapy in Resectable Pancreatic Cancer

University of Zurich

Phase 3 Terminated
38 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT01521702 2015-03-20

NEOPAC

Institut Paoli-Calmettes

Phase 3 Completed
2 enrolled
Gastrointestinal

Adenocarcinoma, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡